Enrico Maiorino
Overview
Explore the profile of Enrico Maiorino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gentili M, Glass K, Maiorino E, Hobbs B, Xu Z, Castaldi P, et al.
PLoS Comput Biol
. 2024 Oct;
20(10):e1011079.
PMID: 39418301
Chronic obstructive pulmonary disease (COPD) is a complex disease influenced by well-established environmental exposures (most notably, cigarette smoking) and incompletely defined genetic factors. The chromosome 4q region harbors multiple genetic...
2.
Bell A, Ram S, Labaki W, Murray S, Kazerooni E, Galban S, et al.
Am J Respir Crit Care Med
. 2024 Sep;
PMID: 39269427
Background: Chronic obstructive pulmonary disease (COPD) exhibits considerable progression heterogeneity. We hypothesized that elastic principal graph analysis (EPGA) would identify distinct clinical phenotypes and their longitudinal relationships. Methods: Cross-sectional data...
3.
Kilic A, Halu A, De Marzio M, Maiorino E, Duvall M, Bruggemann T, et al.
Elife
. 2024 Apr;
12.
PMID: 38567749
Vitamin D possesses immunomodulatory functions and vitamin D deficiency has been associated with the rise in chronic inflammatory diseases, including asthma (Litonjua and Weiss, 2007). Vitamin D supplementation studies do...
4.
Maiorino E, De Marzio M, Xu Z, Yun J, Chase R, Hersh C, et al.
medRxiv
. 2024 Jan;
PMID: 38260473
Chronic Obstructive Pulmonary Disease (COPD) is a complex, heterogeneous disease. Traditional subtyping methods generally focus on either the clinical manifestations or the molecular endotypes of the disease, resulting in classifications...
5.
Decano J, Maiorino E, Matamalas J, Chelvanambi S, Tiemeijer B, Yanagihara Y, et al.
Circulation
. 2023 Oct;
148(19):1459-1478.
PMID: 37850387
Background: Interferon-γ (IFNγ) signaling plays a complex role in atherogenesis. IFNγ stimulation of macrophages permits in vitro exploration of proinflammatory mechanisms and the development of novel immune therapies. We hypothesized...
6.
Maiorino E, Loscalzo J
Arterioscler Thromb Vasc Biol
. 2023 May;
43(7):1111-1123.
PMID: 37226730
The complex landscape of cardiovascular diseases encompasses a wide range of related pathologies arising from diverse molecular mechanisms and exhibiting heterogeneous phenotypes. This variety of manifestations poses significant challenges in...
7.
Baek S, Maiorino E, Kim H, Glass K, Raby B, Yuan K
Front Cardiovasc Med
. 2022 Jun;
9:876591.
PMID: 35722109
Pericytes are mesenchymal-derived mural cells that wrap around capillaries and directly contact endothelial cells. Present throughout the body, including the cardiovascular system, pericytes are proposed to have multipotent cell-like properties...
8.
De Marzio M, Kilic A, Maiorino E, Mitchel J, Mwase C, OSullivan M, et al.
Sci Adv
. 2021 Jul;
7(30).
PMID: 34301595
Epithelial tissue can transition from a jammed, solid-like, quiescent phase to an unjammed, fluid-like, migratory phase, but the underlying molecular events of the unjamming transition (UJT) remain largely unexplored. Using...
9.
Maiorino E, Baek S, Guo F, Zhou X, Kothari P, Silverman E, et al.
Nat Commun
. 2021 Apr;
12(1):2434.
PMID: 33875660
No abstract available.
10.
Baek S, Foer D, Cahill K, Israel E, Maiorino E, Rohl A, et al.
J Pers Med
. 2021 Apr;
11(4).
PMID: 33805900
There is an acute need for advances in pharmacologic therapies and a better understanding of novel drug targets for severe asthma. Imatinib, a tyrosine kinase inhibitor, has been shown to...